Previous Article | Next Article 
Journal of Virology, October 1998, p. 8358-8361, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Two Novel Adenovirus Vector Systems Permitting
Regulated Protein Expression in Gene Transfer Experiments
Magnus
Molin,1
Maria C.
Shoshan,2
Karin
Öhman-Forslund,1,
Stig
Linder,2 and
Göran
Akusjärvi1,*
Department of Medical Biochemistry and
Microbiology, BMC, Uppsala University, S-751 23 Uppsala,1 and
Radiumhemmet's Research
Laboratory, Cancer Center Karolinska, Karolinska Institute and
Hospital, S-171 76 Stockholm,2 Sweden
Received 4 May 1998/Accepted 15 July 1998
 |
ABSTRACT |
Two new adenovirus vector systems based on the
tetracycline-regulated Tet-ON- (Gossen, M., et al., Science
268:1766-1769, 1995) and the RU 486-regulated progesterone antagonist
(Wang, Y., et al., Proc. Natl. Acad. Sci. USA 91:8180-8184,
1994)-induced gene expression systems are described. We show that both
systems permit a tight control of chloramphenicol acetyltransferase
reporter gene expression in a variety of cell types, with induction
levels of approximately 1,800-fold (Tet-ON system) and 600-fold (RU
486-regulated system), respectively. A significant advantage of our
vector systems is that reporter protein expression can be adjusted over
a wide range by varying the amount of inducer. The Tet-ON system is
also shown to permit an efficient control of reporter gene expression in mice.
 |
TEXT |
Recombinant adenovirus protocols
typically make use of strong promoters to achieve high levels of
production of recombinant protein (for reviews see references
1, 5, and 12). However, this
sometimes leads to a problem, since constitutive gene expression is
unphysiological and may interfere with signaling systems in the cell
and lead to cellular toxicity. Thus, gene cassettes permitting regulated expression, on/off switches, and the possibility to fine tune
the level of reporter gene expression are of value in experimental
designs, such as basic studies of protein function, expression of
cytotoxic proteins, and cancer treatment.
Here we describe the construction of two versatile adenovirus vector
systems that allow for regulated reporter gene expression in gene
transfer experiments. A major advantage with the adenovirus-mediated gene expression systems compared to conventional techniques is that
they circumvent the need to establish stable transfected cell lines, a
tedious task that has to be repeated with each cell type to be used.
We have adopted a double-infection strategy to control reporter gene
expression in our vector systems (Fig.
1). In the Tet-ON system the reverse
tetracycline (Tet) repressor protein fused to the herpes simplex virus
(HSV) VP16 transcriptional activation domain (rtTA) (4) was
cloned behind the constitutively active cytomegalovirus (CMV) promoter
and inserted into an adenovirus type 5 (Ad5) dl309
(9) vector (generating virus AdCMVrtTA; Fig. 1). The
chloramphenicol acetyltransferase (CAT) reporter gene was cloned behind
a Tet enhancer consisting of seven tandem Tet operator DNA binding
sites fused to a minimal adenovirus major late promoter/tripartite
leader construct (virus AdTetTripCAT; Fig. 1). Transcription of the CAT
reporter gene is activated by the addition of doxycycline (DOX) to the
culture medium (4).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Diagrams of the Tet-ON and the Prog systems. A
mixed-infection strategy is used to introduce the activator and the CAT
reporter genes to recipient cells. Reporter gene expression is then
activated by the addition of the respective inducer. The Tet and Prog
enhancer sequences were cloned upstream of a minimal major late TATA
promoter element. We fused a cDNA encoding the major late tripartite
leader immediately downstream of the transcription start site, as a 5'
noncoding sequence. The tripartite leader has been shown to function as
an mRNA export signal (8) and a translational enhancer
(15) in late-infected cells. The gene cassettes were
inserted into the E1 region of Ad5 dl309 (9),
making the recombinant adenoviruses replication deficient.
|
|
In the progesterone antagonist-induced gene expression system
(13) (hereafter referred to as the Prog system), a chimeric transactivator protein (13) consisting of the ligand binding domain of hPRB891 fused to the Gal4 DNA binding domain and the HSV VP16
transactivator domain was cloned behind a CMV promoter and inserted
into an Ad5 dl309 (9) vector (generating virus AdCMVProg; Fig. 1). This human progesterone receptor mutant does not
bind progesterone or other endogenous hormones but can still bind the
progesterone antagonist RU 486 (13). The CAT reporter gene
was cloned behind a Gal4 enhancer, consisting of five Gal4 DNA binding
sites fused to a minimal major late promoter/tripartite leader
construct (virus AdG5TripCAT; Fig. 1). Transcription of the CAT
reporter gene is activated by the addition of RU 486 to the culture
medium. More details about the cloning strategy and methods used in
this article are available at www.bmc.uu.se/IMIM/res/GA.html.
One important characteristic expected of the virus vector systems is
the possibility to fine tune reporter gene expression. This is
important in several biological settings, such as studies of basic
protein function in which too-high protein expression may be toxic or
cause unphysiological perturbations of regulatory pathways in the cell.
To test the induction potential of the two vector systems, HeLa cells
were coinfected with 10 PFU per cell of the activator and reporter
viruses belonging to each system. Reporter gene expression was induced
at the start of infection by the addition of increasing amounts of RU
486 or DOX, respectively, and CAT gene expression was measured at
16 h postinfection by CAT enzyme assay (2). As shown in
Fig. 2, CAT activity was undetectable in
both systems in uninduced cells. The addition of increasing amounts of
DOX or RU 486 resulted in a corresponding increase in CAT activity,
with maximum levels of CAT obtained at 4 µM of the respective
inducer. The same dose-response curves were observed in the tested
range of 1 to 20 PFU per cell (data not shown). However, as expected,
the total CAT activity decreased with a lower multiplicity of
infection. Collectively, these results show that the Tet-ON and Prog
systems fulfill the first criterion, namely, that the level of reporter
gene expression can be controlled by varying the amount of inducer or
the multiplicity of infection. The possibility of suppressing reporter
gene expression during virus growth makes it possible to reconstruct
recombinant adenoviruses expressing gene products that interfere with
virus replication (data not shown).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
Dose response for the Prog (A) and the Tet-ON (B)
systems. HeLa cells were coinfected with 10 PFU of the respective
activator and reporter viruses. Increasing amounts of inducer were
added at the start of infection, and cells were harvested at 16 h
postinfection. CAT activity was measured and quantitated by
PhosphorImager scanning. Error bars indicate standard deviations
calculated from three independent experiments.
|
|
To quantitate reporter gene expression, HeLa cells were coinfected with
10 PFU per cell of activator and reporter viruses. The inducer was
added at the start of infection, and CAT protein accumulation was
quantitated at 16 h postinfection by CAT enzyme-linked immunosorbent assay (ELISA) (Boehringer Mannheim). As shown in Fig.
3, addition of the respective inducer
resulted in dramatic induction of CAT protein expression in both the
Prog and Tet-ON systems, with the Prog system consistently yielding a
much higher level of protein expression. The background level of CAT
expression was very low in both systems, making an accurate estimate of
the fold induction difficult. However, assaying uninduced extracts at a
100-fold-higher concentration revealed that the fold induction was
greater for the Tet-ON (approximately 1,800-fold) than for the Prog
system (approximately 600-fold) (details available at www.bmc.uu.se/IMIM/res/GA.html). The levels of CAT protein production with both gene regulatory systems are impressive. Thus, the ratios of
CAT protein produced with the Prog and Tet-On systems, compared to that
of a recombinant adenovirus expressing CAT under the transcriptional control of the constitutively active CMV early promoter (AdCMVCAT), were 140 and 50, respectively (Fig. 3). To determine whether the Prog
and Tet-ON systems could be used for high levels of protein production,
we quantitated CAT expression in 293 cells, which support replication
of the recombinant viruses. Infection with both systems resulted in an
accumulation of approximately 1.5 µg of CAT protein per
106 cells at 24 h postinfection (data not shown).
Since 293 cells can be grown in spinner cultures, this translates to
quantities approximating 1 mg of CAT protein per liter of cells. It
therefore appears realistic that these vector systems can be used for
large-scale recombinant protein production. This alternative is
attractive, since protein modifications specific for different cell
types would be expected to occur correctly.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 3.
Stringent control of reporter gene expression. HeLa
cells were coinfected with 10 PFU of the respective activator and
reporter viruses. The inducer (4 µM) was added at the start of
infection, and cell extracts were prepared at 16 h postinfection.
CAT protein expression was quantitated by using a CAT ELISA kit
(Boehringer Mannheim). The mean value of CAT protein expression,
calculated from seven independent experiments, is shown.
|
|
An important feature expected of our vector systems is the potential to
function in a broad range of cell types. In theory, the major
limitation of our experimental approach would be whether the recipient
cell expresses the adenovirus receptor and coreceptors and thus permits
virus uptake. To test the host range of the viral vectors we infected
Cos-7 (simian virus 40-transformed African green monkey kidney cells),
NIH 3T3 (mouse fibroblasts), and 1523 cells (human foreskin
fibroblasts). As shown in Fig. 4, in all cells we observed a high induction combined with a background equal to
that of uninfected extracts. The Tet-ON system functioned reproducibly
in all cell types tested. In contrast, the Prog system induced CAT
expression efficiently in all cell types except NIH 3T3 cells. Since
the Tet-ON system functioned in this cell type, the failure of the Prog
system was not due to virus uptake but was more likely caused by the
inability of RU 486 to activate the progesterone receptor in this cell
type.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 4.
The Tet-ON and the Prog systems work with similar
efficiencies in several cell types. HeLa cells, Cos-7 cells, NIH 3T3
cells, and 1523 cells were coinfected with 10 PFU per cell of activator
and reporter viruses belonging to the respective systems. Inducer (4 µM) was added at the start of infection, and CAT activity was
measured at 16 h postinfection. For comparison, CAT expression
induced by infection with 20 PFU of AdCMVCAT is shown.
|
|
To determine whether the high levels of induction of CAT protein
expression observed in cell lines also were reproduced in an in vivo
model system, we injected BALB/c mice intramuscularly with mixtures of
AdCMVrtTA and AdTetTripCAT. The results from two independent
experiments are summarized in Fig. 5.
Injected muscles and also lung and liver samples from the same animals were analyzed for CAT expression at various times postinjection. Only
muscle biopsies were found to be positive for CAT, suggesting that the
viruses did not disseminate from the site of injection (data not
shown). Although the amounts of CAT protein detected in the muscle
biopsies varied between individual animals (Fig. 5), DOX treatment
consistently gave a high level of induction of CAT expression. The
observed variability is likely due mainly to two factors: experimental
difficulties in (i) injecting small volumes and in (ii) excision of an
equal size of muscle tissue. However, the results summarized in Fig. 5
demonstrate that the adenovirus Tet-ON vector system permits efficient
control of reporter gene expression also in an animal model system.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Inducible expression of CAT in vivo. Mice were injected
intramuscularly with the indicated PFUs of the Tet-ON system. Muscle
extracts were analyzed for CAT protein expression by CAT ELISA. The
results are presented as nanograms of CAT protein per microgram of
total lysate protein. Bars based on mean values derived from extracts
prepared from multiple animals are indicated, with the number of
animals used shown within brackets at the top. Control animals not
injected or receiving DOX only showed no CAT protein expression (data
not shown).
|
|
During our work we have become aware of other research groups that have
adopted similar experimental strategies to construct adenovirus vectors
for inducible gene expression (for example see references 6,
7, 10, 11, and 14). Most of these reports
are based on recombinant adenoviruses expressing the Tet-OFF system
(3). This system does not, contrary to results with our
Tet-ON or Prog systems, allow for the rapid induction of reporter gene
expression since the tetracycline needs to be washed out or consumed
for gene activation. This may be critical in studies in which kinetic
parameters play a role. It is also worth pointing out that our Prog and
Tet-ON systems may very well be used in conjunction with each other,
permitting independent control of expression of two different proteins
in an experimental set up (data not shown).
 |
ACKNOWLEDGMENTS |
We thank Lars-Gunnar Larsson for the kind gift of 1523 cells and
Neil Portwood for much help during the initial stages of this project.
RU 486 was kindly provided by ROUSSEL-UCLAF.
This work was supported by the Swedish Cancer Society.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Biochemistry and Microbiology, BMC, Box 582, Uppsala
University, S-751 23 Uppsala, Sweden. Phone: 46-18-471 4164. Fax:
46-18-50 98 76. E-mail: goran.akusjarvi{at}imim.uu.se.
Present address: Department of Virology, The National Veterinary
Institute, BMC, S-751 23 Uppsala, Sweden.
 |
REFERENCES |
| 1.
|
Berkner, K. L.
1992.
Expression of heterologous sequences in adenoviral vectors.
Curr. Top. Microbiol. Immunol.
158:39-66[Medline].
|
| 2.
|
Bondesson, M.,
K. Öhman,
M. Mannervik,
S. Fan, and G. Akusjärvi.
1996.
Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter.
J. Virol.
70:3844-3851[Abstract].
|
| 3.
|
Gossen, M., and H. Bujard.
1992.
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Proc. Natl. Acad. Sci. USA
89:5547-5551[Abstract/Free Full Text].
|
| 4.
|
Gossen, M.,
S. Freundlieb,
G. Bender,
G. Müller,
W. Hillen, and H. Bujard.
1995.
Transcriptional activation by tetracyclines in mammalian cells.
Science
268:1766-1769[Abstract/Free Full Text].
|
| 5.
|
Graham, F. L., and L. Prevec.
1992.
Adenovirus-based expression vectors and recombinant vaccines, p. 363-390.
In
R. W. Ellis (ed.), Vaccines: new approaches to immunological problems. Butterworth-Heinemann, Boston, Mass.
|
| 6.
|
Harding, T. C.,
B. J. Geddes,
D. Murphy,
D. Knight, and J. B. Uney.
1998.
Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system.
Nat. Biotechnol.
16:553-555[Medline].
|
| 7.
|
Hu, S.-X.,
W. Ji,
Y. Zhou,
C. Logothetis, and H.-J. Xu.
1997.
Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor gene expression.
Cancer Res.
57:3339-3343[Abstract/Free Full Text].
|
| 8.
|
Huang, W., and S. J. Flint.
1998.
The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export.
J. Virol.
72:225-235[Abstract/Free Full Text].
|
| 9.
|
Jones, N., and T. Shenk.
1978.
Isolation of deletion and substitution mutants of adenovirus type 5.
Cell
13:181-188[Medline].
|
| 10.
|
Massie, B.,
F. Couture,
L. Lamoureux,
D. D. Mosser,
C. Guilbault,
P. Jolicoeur,
F. Bélanger, and Y. Langelier.
1998.
Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.
J. Virol.
72:2289-2296[Abstract/Free Full Text].
|
| 11.
|
Neering, S. J.,
S. F. Hardy,
D. Minamoto,
S. K. Spratt, and C. T. Jordan.
1996.
Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors.
Blood
4:1147-1155.
|
| 12.
|
Trapnell, B. C., and M. Gorzilla.
1994.
Gene therapy using adenoviral vectors.
Curr. Opin. Biotechnol.
5:617-625[Medline].
|
| 13.
|
Wang, Y.,
B. W. O'Malley, Jr.,
S. Y. Tsai, and B. W. O'Malley.
1994.
A regulatory system for use in gene transfer.
Proc. Natl. Acad. Sci. USA
91:8180-8184[Abstract/Free Full Text].
|
| 14.
|
Yoshida, Y., and H. Hamada.
1997.
Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.
Biochem. Biophys. Res. Commun.
230:426-430[Medline].
|
| 15.
|
Yueh, A., and R. J. Schneider.
1996.
Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells.
Genes Dev.
15:1557-1567.
|
Journal of Virology, October 1998, p. 8358-8361, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ohrmalm, C., Akusjarvi, G.
(2006). Cellular Splicing and Transcription Regulatory Protein p32 Represses Adenovirus Major Late Transcription and Causes Hyperphosphorylation of RNA Polymerase II.. J. Virol.
80: 5010-5020
[Abstract]
[Full Text]
-
Barbu, A. R., Akusjarvi, G., Welsh, N.
(2005). Adenoviral-Mediated Transduction of Human Pancreatic Islets: Importance of Adenoviral Genome for Cell Viability and Association with a Deficient Antiviral Response. Endocrinology
146: 2406-2414
[Abstract]
[Full Text]
-
Fleming, S. L., Shank, P. R., Boekelheide, K.
(2003). {gamma}-Tubulin Overexpression in Sertoli Cells In Vivo: I. Localization to Sites of Spermatid Head Attachment and Alterations in Sertoli Cell Microtubule Distribution. Biol. Reprod.
69: 310-321
[Abstract]
[Full Text]
-
Edholm, D., Molin, M., Bajak, E., Akusjarvi, G.
(2001). Adenovirus Vector Designed for Expression of Toxic Proteins. J. Virol.
75: 9579-9584
[Abstract]
[Full Text]
-
Halford, W. P., Kemp, C. D., Isler, J. A., Davido, D. J., Schaffer, P. A.
(2001). ICP0, ICP4, or VP16 Expressed from Adenovirus Vectors Induces Reactivation of Latent Herpes Simplex Virus Type 1 in Primary Cultures of Latently Infected Trigeminal Ganglion Cells. J. Virol.
75: 6143-6153
[Abstract]
[Full Text]
-
Mandic, A., Viktorsson, K., Molin, M., Akusjärvi, G., Eguchi, H., Hayashi, S.-I., Toi, M., Hansson, J., Linder, S., Shoshan, M. C.
(2001). Cisplatin Induces the Proapoptotic Conformation of Bak in a {Delta}MEKK1-Dependent Manner. Mol. Cell. Biol.
21: 3684-3691
[Abstract]
[Full Text]
-
Molin, M., Akusjärvi, G.
(2000). Overexpression of Essential Splicing Factor ASF/SF2 Blocks the Temporal Shift in Adenovirus Pre-mRNA Splicing and Reduces Virus Progeny Formation. J. Virol.
74: 9002-9009
[Abstract]
[Full Text]